TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of change in GA lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of unsolicited systemic adverse events (AEs) reported in the 30 minutes after each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of solicited administration site reactions within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of aetiology of gallbladder stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Stroke Specific Quality Of Life (SS-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perception of Labour Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort of Birth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pocket closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Communication self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptoms and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subjects satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average number of clinics attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median Satisfaction Survey Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hand ScleroDerma Lived Experience Scale (HAnDE Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma Pharmacokinetic-AUC 0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Pharmacokinetic-AUC 0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Pharmacokinetic-Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Study Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of Participant Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of Adherence to Diet
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of Adherence to Physical Activity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Correct Ratings for /r/ Sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in terminal hair counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YO Sperm Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Depression Anxiety Stress Scale - 21
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cmax: Maximum Observed Plasma Concentration for TAK-227
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-227
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC∞: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity for TAK-227
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (PR + CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of conversation turns
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Receptive lexical level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of pre-fracture function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient perceptions of mHealth platform
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: treatment compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: safety of use of oral contraceptives in this population
Endpoint domain: Adverse events/effects
Primary endpoint: Rise and fall of urine luteinizing hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rise in urine progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in FSH and estrogen (E3G)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients dead or requiring IMV or ECMO by day 28
Endpoint domain: Mortality/survival
Primary endpoint: Time to first requirement of rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder pain and disability level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Response
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Jebsen Taylor Hand dysfunction test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant improvement in albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet counts over time during the course of fostamatinib therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ITP-PAQ Quality of life measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SF-36 Quality of life measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Variation of reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-operative severe pancreatic fistula
Endpoint domain: Adverse events/effects
Primary endpoint: elbow proprioception assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient linkage to outpatient program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of true positive seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of false positive seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Number of false negative seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody concentrations in maternal and cord blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: KOOS JR Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Score in Numerical Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score for SCORing Atopic Dermatitis (SCORAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of bevacizumab- IRDye800CW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Who Noticed Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Out Patient Department attendance
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: malaria related mortality
Endpoint domain: Mortality/survival
Primary endpoint: COPD self-efficacy scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: chronic disease care assessment scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Glycosylated Hemoglobin (HgB A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of the intervention group who would like to continue the EA-LCS framework
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of the intervention group who would recommend the EA-LCS framework to other programs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants who would describe the framework as workable
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Hemoglobin after 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of participants with >= 2 g/dL increase in hemoglobin level from Baseline in the absence of transfusion for weekly dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of participants with >= 2 g/dL increase in hemoglobin level from Baseline in the absence of transfusion for biweekly dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient-reported PICS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in the Disease Specific Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in the Generic Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in the Burn Rehabilitation Knowledge Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression-Free Survival Rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Total Costs Associated With Hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Risk of flare-ups of underlying immunoreumatologic disease
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of complications during the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of complications during PMA pregnancies
Endpoint domain: Adverse events/effects
Primary endpoint: Breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Preoperative serum thyroglobulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cardiac dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Success of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD Rating Scale (ADHD-RS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of retrieved lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Forearm vascular conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of participants reaching daily vegetable intake targets
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Pain levels in the first 16 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level 36 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average percent heart rate maximum (HR max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average repetition maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of days per week exercised
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Progression-free survival rate (PFSR) at 4 months
Endpoint domain: Mortality/survival
Primary endpoint: Osteocalcin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline PTSD Checklist for DSM-5 8-item (PCL8-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of subjects achieving objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Confirmed conversion of circulating tumor cell count (CTC) to <5/7.5 mL blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PSA decline ≥ 50% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stable disease ≥ 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: aGVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: long-term efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal weight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in electrical activity associated with memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in electrical activity associated with language
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in electrical activity associated with emotions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in electrical activity associated with movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in electrical activity associated with attention and executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in electrical activity associated with sound perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nose smell-print
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of overall adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with participation in the Restart programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone width and height gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Osteoporosis knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Muscle Cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Resolution of steatohepatitis with no worsening of fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Complication free Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of diverticular flares/attacks since FMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of emergency room visits and hospitalizations due to diverticulitis since FMT
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of courses of antibiotics required for the treatment of diverticulitis since FMT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number and severity of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects discontinuing prematurely from treatment due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: level of ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of patient sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause Death Rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Procedure-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: duration and number of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of inflammatory markers (CBC, CRP, Ferritin and D-dimer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for hospital admission, ICU admission, mechanical ventilation and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Clinical usability of the non-adhesive applicator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Distant metastases
Endpoint domain: Adverse events/effects
Primary endpoint: Active Movement Scale - Motor Function Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flacc Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS overall response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants experience of the CGA-Q
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact on person-centred care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Total amount of OPG in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Treatment Success at 3-Month Post-Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Treatment Success at 6-Month Post-Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Treatment Success at 12-Month Post-Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Phosphocreatine recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adherence to a healthy lifestyle score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Verbal episodic memory change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual episodic memory change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Working memory change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: RAC performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular chlamydia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of in-hospital mortality after cardiogenic shock
Endpoint domain: Mortality/survival
Primary endpoint: Vaso-inotropic score after cardiogenic shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: scores at the TAM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time used for suturing the surgical site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical remission of immune-mediated diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Seroconversion rate of the antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of the antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intestinal microbiota assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Upper extremity functional performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Spike speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic evaluation of accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on the Spanish Short Self-Regulation Questionnaire (SSSRQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confirmed Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Executive Function composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total BDNF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Students' reported Prosocial Bystander Behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Students' reported Sexually Violent Behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of chronic His pacing success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance of tube movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of scores of erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline of scores of desquamation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline of scores of blistering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline of scores of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Size of the thyroid cystic nodule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal Defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes